Open Access
Arbidol: a quarter-century after. Past, present and future of the original Russian antiviral
Publication type: Journal Article
Publication date: 2018-06-01
scimago Q1
wos Q1
SJR: 0.811
CiteScore: 12.9
Impact factor: 6.0
ISSN: 0036021X, 14684837
DOI:
10.1070/RCR4791
General Chemistry
Abstract
The present review is concerned with the synthesis and structure–activity relationship studies of Arbidol and its structural analogues. The latter are roughly divided into several unequal parts: indole- and benzofuran-based compounds, benzimidazole and imidazopyridine bioisosteres and ring-expanded quinoline derivatives. Much attention is focused on various types of antiviral activity of the above-mentioned Arbidol congeners, as well as of the parent compound itself. Features of Arbidol synthesis and metabolic changes are also discussed.
The bibliography includes 166 references.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
|
|
|
Advances in Heterocyclic Chemistry
3 publications, 20%
|
|
|
Science of the Total Environment
1 publication, 6.67%
|
|
|
Combinatorial Chemistry and High Throughput Screening
1 publication, 6.67%
|
|
|
Mini-Reviews in Medicinal Chemistry
1 publication, 6.67%
|
|
|
Molecules
1 publication, 6.67%
|
|
|
Nature Communications
1 publication, 6.67%
|
|
|
European Journal of Medicinal Chemistry
1 publication, 6.67%
|
|
|
Journal of Heterocyclic Chemistry
1 publication, 6.67%
|
|
|
European Journal of Organic Chemistry
1 publication, 6.67%
|
|
|
Asian Journal of Organic Chemistry
1 publication, 6.67%
|
|
|
Russian Chemical Bulletin
1 publication, 6.67%
|
|
|
Bioorganic Chemistry
1 publication, 6.67%
|
|
|
Russian Chemical Reviews
1 publication, 6.67%
|
|
|
1
2
3
|
Publishers
|
1
2
3
4
5
6
|
|
|
Elsevier
6 publications, 40%
|
|
|
Wiley
3 publications, 20%
|
|
|
Bentham Science Publishers Ltd.
2 publications, 13.33%
|
|
|
Springer Nature
2 publications, 13.33%
|
|
|
MDPI
1 publication, 6.67%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 6.67%
|
|
|
1
2
3
4
5
6
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
15
Total citations:
15
Citations from 2024:
4
(26.66%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Balakin K. V. et al. Arbidol: a quarter-century after. Past, present and future of the original Russian antiviral // Russian Chemical Reviews. 2018. Vol. 87. No. 6. pp. 509-552.
GOST all authors (up to 50)
Copy
Balakin K. V., Filosa R., Lavrenov S. N., Mkrtchyan A. S., Nawrozkij M. B., Novakov I. A. Arbidol: a quarter-century after. Past, present and future of the original Russian antiviral // Russian Chemical Reviews. 2018. Vol. 87. No. 6. pp. 509-552.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1070/RCR4791
UR - https://doi.org/10.1070/RCR4791
TI - Arbidol: a quarter-century after. Past, present and future of the original Russian antiviral
T2 - Russian Chemical Reviews
AU - Balakin, Konstantin V.
AU - Filosa, Rosanna
AU - Lavrenov, Sergey N
AU - Mkrtchyan, Arthur S
AU - Nawrozkij, Maxim B
AU - Novakov, Ivan A
PY - 2018
DA - 2018/06/01
PB - Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
SP - 509-552
IS - 6
VL - 87
SN - 0036-021X
SN - 1468-4837
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2018_Balakin,
author = {Konstantin V. Balakin and Rosanna Filosa and Sergey N Lavrenov and Arthur S Mkrtchyan and Maxim B Nawrozkij and Ivan A Novakov},
title = {Arbidol: a quarter-century after. Past, present and future of the original Russian antiviral},
journal = {Russian Chemical Reviews},
year = {2018},
volume = {87},
publisher = {Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii},
month = {jun},
url = {https://doi.org/10.1070/RCR4791},
number = {6},
pages = {509--552},
doi = {10.1070/RCR4791}
}
Cite this
MLA
Copy
Balakin, Konstantin V., et al. “Arbidol: a quarter-century after. Past, present and future of the original Russian antiviral.” Russian Chemical Reviews, vol. 87, no. 6, Jun. 2018, pp. 509-552. https://doi.org/10.1070/RCR4791.